开能健康：拟收购原能集团部分子公司 加强在细胞产业的投资布局

Core Viewpoint - The company, Kaineng Health, has signed a framework agreement to acquire all equity and assets of several related companies from Yuaneng Cell Technology Group to strengthen its investment in the cell industry, aiming to establish it as a second growth curve for the company [1] Group 1: Acquisition Details - The acquisition involves cash payment for the complete ownership of Yuaneng Group's subsidiaries, including Yuantian Biological, Jiyuan Meiyu, Kele Cat, and Lishui Dongxin [1] - Post-acquisition, Yuaneng Group will retain its core park assets, cell storage business, and cell deployment business [1] - Yuaneng Group is also responsible for a project related to the "cell automation manufacturing factory" as mandated by a national ministry [1] Group 2: Current Holdings and Future Support - Currently, the company holds a 43.70% stake in Yuaneng Group [1] - The company will continue to support the development of related industries following the acquisition [1]